Overall rank by patents
#1,285
Across all tracked assignees
USPTO PatentsView assignee record - 329 granted patents across 18 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61Q (SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS).
The verdict
MARY holds 329 US patents across 18 technology areas, rank #1,285 of 50,000 tracked assignees.
MARY KAY Inc has been granted 329 US utility patents between 2015 and 2025, placing MARY KAY Inc at rank #1,285 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.9 claims per patent with primary concentration in A61Q (SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS). As a US Corporation, MARY KAY Inc is one of the more focused assignees in the PatentsView dataset. By volume, MARY sits between Rheem Manufacturing Company (330 patents, rank #1,281) and Yissum Research Development Company OF THE Hebrew University OF Jerusalem Ltd. (329 patents, rank #1,289) - the closest US assignees by grant volume. The composite Innovation Score of 47.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 157 grants, compared with 172 in the 2015–2019 window, a -9% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. MARY KAY Inc's 10.9 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark MARY KAY Inc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Rheem Manufacturing Company
330 patents
SOUTHWEST RESEARCH INSTITUTE
330 patents
THYSSENKRUPP PRESTA AKTIENGESELLSCHAFT
330 patents
KunShan Go-Visionox Opto-Electronics Co., Ltd
329 patents
Monolithic 3D Inc.
329 patents
Quest Diagnostics Investments LLC
329 patents
SEW-EURODRIVE GMBH & CO. KG
329 patents
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
329 patents
MARY KAY INC
329 patents
What this shows MARY holds 329 patents at rank #1,285, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,285 in granted patent volume.
Other assignees with the most granted patents in MARY's primary technology class.
MARY's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 29 | 8.8% |
| 2016 | 32 | 9.7% |
| 2017 | 35 | 10.6% |
| 2018 | 34 | 10.3% |
| 2019 | 42 | 12.8% |
| 2020 | 29 | 8.8% |
| 2021 | 22 | 6.7% |
| 2022 | 17 | 5.2% |
| 2023 | 40 | 12.2% |
| 2024 | 31 | 9.4% |
| 2025 | 18 | 5.5% |
Top 15 of 18 technology areas
Overall rank by patents
#1,285
Across all tracked assignees
47.9 out of 100
How to use this portfolio
MARY's 329 grants land it in the top 18% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.